Because ST14/Prss14 can be activated by an autoactivation mechanism, it may work as a master key activating these substrates and thus initiating various signaling pathways on cancer cells (and/or stromal and immune cells nearby) during ER− breast cancer progression and metastasis. This evidence concerns the gene ST14 and cancer.